Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 5, 2005
Development of dual-acting benzofurans for thromboxane A2 receptor antagonist and prostacyclin receptor agonist: synthesis, structure-activity relationship, and evaluation of benzofuran derivativesMichihiro Ohno, Mitsuko Miyamoto, Kazuhiro Hoshi, et al.Epileptic Disorders : International Epilepsy Journal with Videotape|December 19, 2012
Adversive seizures associated with periodic lateralised epileptiform discharges (PLEDs) after left orbital contusionTakahiro Takeda, Mikio Osawa, Sono Toi, et al.Optics Express|June 11, 2008
Two-dimensional simulation of holographic data storage medium for multiplexed recordingMitsuru Toishi, Takahiro Takeda, Kenji Tanaka, et al.Clinical Neuropathology|March 28, 2022
Prolonged central motor conduction time and pyramidal tract degeneration in amyotrophic lateral sclerosisTakahiro Takeda, Mutsumi Iijima, Misa Seki, et al.Journal of Neuropathology and Experimental Neurology|May 2, 2015
TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral SclerosisTakahiro Takeda, Mutsumi Iijima, Toshiki Uchihara, et al.Bioorganic & Medicinal Chemistry|November 22, 2005
Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonistsMichihiro Ohno, Yoichiro Tanaka, Mitsuko Miyamoto, et al.Developmental Biology|July 25, 2012
Germ cells are not the primary factor for sexual fate determination in goldfishRie Goto, Taiju Saito, Takahiro Takeda, et al.Rinsho Shinkeigaku = Clinical Neurology|February 18, 2005
[Bucillamine-induced dermatomyositis-like clinical features in a patient with rheumatoid arthritis]Takahiro Takeda, Yuko Shimizu, Megumi Takeuchi, et al.Internal Medicine (Tokyo, Japan)|June 26, 2012
Rituximab used successfully in the treatment of anti-NMDA receptor encephalitisRyotaro Ikeguchi, Koichi Shibuya, Shigeo Akiyama, et al.BMC Neurology|December 14, 2022
A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical studyShigeki Hirano, Akira Kojima, Yoko Nakayama, et al.Pageof 4